Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wesson, J. A.
Right arrow Articles by Hughes, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wesson, J. A.
Right arrow Articles by Hughes, J.
J Am Soc Nephrol 14:139-147, 2003
© 2003 American Society of Nephrology

Osteopontin Is a Critical Inhibitor of Calcium Oxalate Crystal Formation and Retention in Renal Tubules

Jeffrey A. Wesson*, Richard J. Johnson§, Marrilda Mazzali{dagger}, Anne M. Beshensky*, Susan Stietz{dagger}, Ceci Giachelli{dagger}, Lucy Liaw{dagger}, Charles E. Alpers{dagger}, William G. Couser{dagger}, Jack G. Kleinman* and Jeremy Hughes{dagger}

*Department of Veterans Affairs Medical Center and Medical College of Wisconsin, Milwaukee, Wisconsin; {dagger}University of Washington, Seattle, Washington; {ddagger}Maine Medical Center Research Institute, University of Maine, Maine; §Baylor College of Medicine, Houston, Texas.

Correspondence to Dr. Jeremy Hughes, Phagocyte Laboratory, MRC Center for Inflammation Research, University of Edinburgh Medical School, Teviot Place, Edinburgh, EH8 9AG, United Kingdom. Phone: 44-131-6511574; Fax: 44-131-6511607;

ABSTRACT. Calcium nephrolithiasis is the most common form of renal stone disease, with calcium oxalate (CaOx) being the predominant constituent of renal stones. Current in vitro evidence implicates osteopontin (OPN) as one of several macromolecular inhibitors of urinary crystallization with potentially important actions at several stages of CaOx crystal formation and retention. To determine the importance of OPN in vivo, hyperoxaluria was induced in mice targeted for the deletion of the OPN gene together with wild-type control mice. Both groups were given 1% ethylene glycol, an oxalate precursor, in their drinking water for up to 4 wk. At 4 wk, OPN-deficient mice demonstrated significant intratubular deposits of CaOx crystals, whereas wild-type mice were completely unaffected. Retained crystals in tissue sections were positively identified as CaOx monohydrate by both polarized optical microscopy and x-ray powder diffraction analysis. Furthermore, hyperoxaluria in the OPN wild-type mice was associated with a significant 2- to 4-fold upregulation of renal OPN expression by immunocytochemistry, lending further support to a renoprotective role for OPN. These data indicate that OPN plays a critical renoprotective role in vivo as an inhibitor of CaOx crystal formation and retention in renal tubules. E-mail: jeremy.hughes@ed.ac.uk




This article has been cited by other articles:


Home page
J. Physiol.Home page
J. S. Clark, D. H. Vandorpe, M. N. Chernova, J. F. Heneghan, A. K. Stewart, and S. L. Alper
Species differences in Cl- affinity and in electrogenicity of SLC26A6-mediated oxalate/Cl- exchange correlate with the distinct human and mouse susceptibilities to nephrolithiasis
J. Physiol., March 1, 2008; 586(5): 1291 - 1306.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. Mo, L. Liaw, A. P. Evan, A. J. Sommer, J. C. Lieske, and X.-R. Wu
Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both
Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1935 - F1943.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Scatena, L. Liaw, and C. M. Giachelli
Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease
Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2302 - 2309.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
A. Taller, B. Grohe, K. A. Rogers, H. A. Goldberg, and G. K. Hunter
Specific Adsorption of Osteopontin and Synthetic Polypeptides to Calcium Oxalate Monohydrate Crystals
Biophys. J., September 1, 2007; 93(5): 1768 - 1777.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. J. De Yoreo, S. R. Qiu, and J. R. Hoyer
Molecular modulation of calcium oxalate crystallization.
Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1123 - F1132.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. C. Salido, X. M. Li, Y. Lu, X. Wang, A. Santana, N. Roy-Chowdhury, A. Torres, L. J. Shapiro, and J. Roy-Chowdhury
Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer
PNAS, November 28, 2006; 103(48): 18249 - 18254.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K. E. White, T. E. Larsson, and M. J. Econs
The Roles of Specific Genes Implicated as Circulating Factors Involved in Normal and Disordered Phosphate Homeostasis: Frizzled Related Protein-4, Matrix Extracellular Phosphoglycoprotein, and Fibroblast Growth Factor 23
Endocr. Rev., May 1, 2006; 27(3): 221 - 241.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. W. Freel, M. Hatch, M. Green, and M. Soleimani
Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice
Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G719 - G728.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
X. Sheng, M. D. Ward, and J. A. Wesson
Crystal Surface Adhesion Explains the Pathological Activity of Calcium Oxalate Hydrates in Kidney Stone Formation
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1904 - 1908.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. T. F. Wolf, I. Zalewski, F. C. Martin, R. Ruf, D. Muller, H. C. Hennies, S. Schwarz, F. Panther, M. Attanasio, H. G. Acosta, et al.
Mapping a new suggestive gene locus for autosomal dominant nephrolithiasis to chromosome 9q33.2-q34.2 by total genome search for linkage
Nephrol. Dial. Transplant., May 1, 2005; 20(5): 909 - 914.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Sheng, T. Jung, J. A. Wesson, and M. D. Ward
From The Cover: Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents
PNAS, January 11, 2005; 102(2): 267 - 272.
[Abstract] [Full Text] [PDF]


Home page
Crit. Rev. Oral Biol. Med.Home page
P. S.N. Rowe
THE WRICKKENED PATHWAYS OF FGF23, MEPE AND PHEX
Crit. Rev. Oral. Biol. Med., September 1, 2004; 15(5): 264 - 281.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. A. Sorokina, J. A. Wesson, and J. G. Kleinman
An Acidic Peptide Sequence of Nucleolin-Related Protein Can Mediate the Attachment of Calcium Oxalate to Renal Tubule Cells
J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2057 - 2065.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Umekawa, Y. Hatanaka, T. Kurita, and S. R. Khan
Effect of Angiotensin II Receptor Blockage on Osteopontin Expression and Calcium Oxalate Crystal Deposition in Rat Kidneys
J. Am. Soc. Nephrol., March 1, 2004; 15(3): 635 - 644.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Asselman, A. Verhulst, M. E. de Broe, and C. F. Verkoelen
Calcium Oxalate Crystal Adherence to Hyaluronan-, Osteopontin-, and CD44-Expressing Injured/Regenerating Tubular Epithelial Cells in Rat Kidneys
J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3155 - 3166.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP